Sparrow Acoustics Inc., dba Sparrow Bioacoustics Inc., closed a C$10 million (US$7.15 million) financing round to support ...

Two in five preclinical studies on subarachnoid hemorrhage (SAH) published in peer-reviewed scientific journals contain ...

Pfizer Inc. is threatening legal action at an attempt by Novo Nordisk A/S to scupper its acquisition of Metsera Inc., with an unsolicited $9 billion offer for the anti-obesity specialist. That trumps ...

With a modest $7 million up front but an ultimate payout potentially topping $1 billion on the line, Modex Therapeutics Inc.

Australian scientists have developed a simpler, less invasive way to detect Alzheimer’s disease that could make it easier for ...

Zag Bio Inc. came out of stealth mode with $80 million in funding so far, including a recently closed series A financing, to ...

Shooting for further proof of durable, drug-free, disease-free remission with a single dose of KYV-101 in generalized ...

The DeGregorio Family Foundation, with support from the Esophageal Cancer Awareness Association, has awarded an additional ...

Qyuns Therapeutics Co. Ltd. has entered into a collaboration and license agreement with F. Hoffmann-La Roche Ltd. granting ...

Exousia Pro Inc.’s subsidiary, Exousia AI, has received orphan drug designation from the FDA for its exosome-based treatment ...

Various derivatives of α-D-tocopherol (vitamin E) have shown antitumor potential by inhibiting metabolic processes in ...

CDR-609 is a T-cell engager therapeutic from CDR-Life Inc. that targets Leucine-rich repeat-containing G protein-coupled ...